BioSyent (CVE:RX) Shares Pass Above Fifty Day Moving Average of $10.25

Shares of BioSyent Inc. (CVE:RX) passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$10.25 and traded as high as C$10.68. BioSyent shares last traded at C$10.68, with a volume of 100 shares trading hands.

BioSyent Trading Up 0.8 %

The business has a 50 day moving average price of C$10.25 and a 200 day moving average price of C$9.39. The company has a current ratio of 6.13, a quick ratio of 6.91 and a debt-to-equity ratio of 3.19. The company has a market capitalization of C$123.78 million, a P/E ratio of 17.80 and a beta of 0.93.

Insider Buying and Selling

In related news, insider FAX Capital Corp. sold 500,000 shares of the stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of C$10.05, for a total transaction of C$5,025,000.00. In the last three months, insiders sold 502,178 shares of company stock valued at $5,046,813. 34.21% of the stock is owned by corporate insiders.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.